You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

jnj-77242113

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Plaque Psoriasis Trial (JNJ-77242113, JNJ-77242113 Matching Placebo, Deucravacitinib)

Not yet recruiting
  • Plaque Psoriasis
  • JNJ-77242113
  • +3 more
  • (no location specified)
Nov 16, 2023

Colitis, Ulcerative Trial (JNJ-77242113, Placebo)

Not yet recruiting
  • Colitis, Ulcerative
  • JNJ-77242113
  • Placebo
  • (no location specified)
Sep 15, 2023

Healthy Trial in Beijing (JNJ-77242113)

Not yet recruiting
  • Healthy
  • JNJ-77242113
  • Beijing, China
    Peking University Third Hospital
Jan 20, 2023

Healthy Trial in Fukuoka (JNJ-77242113, Placebo)

Completed
  • Healthy
  • JNJ-77242113
  • Placebo
  • Fukuoka, Japan
    Souseikai Hakata Clinic
Nov 22, 2022

Plaque Psoriasis Trial in United States (JNJ-77242113, Placebo)

Recruiting
  • Plaque Psoriasis
  • JNJ-77242113
  • Placebo
  • Rolling Meadows, Illinois
  • +6 more
Oct 18, 2023

Plaque Psoriasis Trial in United States (JNJ-77242113, Placebo)

Recruiting
  • Plaque Psoriasis
  • JNJ-77242113
  • Placebo
  • Rolling Meadows, Illinois
  • +8 more
Oct 18, 2023

Plaque Psoriasis Trial in Worldwide (JNJ-77242113, Placebo)

Active, not recruiting
  • Plaque Psoriasis
  • JNJ-77242113
  • Placebo
  • Beverly Hills, California
  • +33 more
Jan 17, 2023

Plaque Psoriasis Trial in Worldwide (JNJ-77242113, Placebo)

Completed
  • Plaque Psoriasis
  • JNJ-77242113
  • Placebo
  • Phoenix, Arizona
  • +75 more
Jan 17, 2023

Plaque Psoriasis Trial in Worldwide (JNJ-77242113)

Recruiting
  • Plaque Psoriasis
  • JNJ-77242113
  • Phoenix, Arizona
  • +80 more
Jan 17, 2023